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CCN2/CTGF is a multifunctional growth factor. Our
previous studies have revealed that CCN2 plays impor-
tant roles in both growth and differentiation of chondro-
cytes and that the 3-untranslated region (3-UTR) of
ccn2 mRNA contains a cis-repressive element of gene
expression. In the present study, we found that the sta-
bility of chicken ccn2 mRNA is regulated in a differen-
tiation stage-dependent manner in chondrocytes. We
also found that stimulation by bone morphogenetic pro-
tein 2, platelet-derived growth factor, and CCN2 stabi-
lized ccn2 mRNA in proliferating chondrocytes but that
it destabilized the mRNA in prehypertrophic-hyper-
trophic chondrocytes. The results of a reporter gene
assay revealed that the minimal repressive cis-element
of the 3-UTR of chicken ccn2 mRNA was located within
the area between 100 and 150 bases from the polyadenyl-
ation tail. Moreover, the stability of ccn2 mRNA was
correlated with the interaction between this cis-element
and a putative 40-kDa trans-factor in nuclei and cyto-
plasm. In fact, the binding between them was prominent
in proliferating chondrocytes and attenuated in (pre)hy-
pertrophic chondrocytes. Stimulation by the growth fac-
tors repressed the binding in proliferating chondro-
cytes; however, it enhanced it in (pre)hypertrophic
chondrocytes. Therefore, gene expression of ccn2 mRNA
during endochondral ossification is properly regulated,
at least in part, by changing the stability of the mRNA,
which arises from the interaction between the RNA cis-
element and putative trans-factor.
Bone is formed by endochondoral ossification and intramem-
bane ossification. During endochondral ossification (reviewed
in Ref. 1), chondrocytes first proliferate; then they become
mature cells, which produce extracellular matrix compounds
such as type II collagen and aggrecan. Thereafter, the cells
eventually differentiate into the hypertrophic chondrocytes,
which produce type X collagen and alkaline phosphatase. At
the terminal stage of endochondral ossification, the cartilage
matrix becomes mineralized and is invaded by blood vessels,
and the chondrocytes are thought to undergo apoptosis.
Through this process, cartilage is replaced by bone. A number
of hormones, such as parathyroid hormone (2) and active forms
of vitamin D3 (2–4), and growth factors, such as fibroblast
growth factor-2 (5), transforming growth factor- (TGF-1 (6,
7)), bone morphogenetic proteins (BMPs (8–10)), parathyroid
hormone-related protein (2,10), and platelet-derived growth
factor (PDGF (11)), have been reported to be involved in the
proliferation and differentiation of chondrocytes during endo-
chondral ossification.
CCN2 (connective tissue growth factor/hypertrophic chon-
drocyte-specific gene product number 24: CTGF/Hcs24) is a
cysteine-rich secretory protein of 36–38 kDa; it belongs in the
CCN family (reviewed in Refs. 12–16), which consists of ccn1
(cef-10/cyr61 (17, 18)), ccn2 (ctgf/hcs24/fisp12 (19–22)), ccn3
(nov (23)), and several related genes such as ccn4 (elm-1/wisp-1
(24, 25)), ccn5 (ctgf-3/wisp-2/cop1 (25, 26), and ccn6 (wisp-3
(25)). CCN2 was initially isolated from angioendothelial cells
as a growth factor related to PDGF and was shown to have
PDGF-like mitogenic and chemotactic activities for fibroblasts
(19, 27–30). Nowadays, however, CCN2 is no longer regarded
as an accessory factor of PDGF but has been shown to be a
multifunctional growth factor that regulates the growth and/or
differentiation of various cells, including vascular endothelial
cells (19, 31–33). Furthermore, we have reported that CCN2
stimulates both the growth and differentiation of chondrocytes
and osteoblasts (22, 34, 35), indicating crucial roles of CCN2 in
endochondral ossification.
These findings pointing to multiple physiological and/or
pathological roles of CCN2 indicate that the gene expression of
ccn2 is regulated at multiple steps, such as transcriptional,
post-transcriptional, and translational. However, as to the mo-
lecular regulatory mechanisms governing ccn2 gene expres-
sion, although a few studies have been reported, most of these
mechanisms still remain to be investigated. For instance,
TGF- induces the expression of CCN2 (22, 27), and a TGF-
response element was found in the ccn2 promoter region (36,
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nism of ccn2 transcription, we reported that the gene expres-
sion is also regulated by its 3-untranslated region (3-UTR) at
post-transcriptional stages (38–40) and that its repressive ef-
fect is functionally conserved between mammalian and avian
species (41).
In the present study, we reveal that gene expression of
chicken ccn2 mRNA is regulated not only transcriptionally, but
also post-transcriptionally during the differentiation of chon-
drocytes and that a cis-element in the 3-UTR of ccn2 mRNA
and its putative trans-factor counterpart collaboratively play
an important role in the post-transcriptional regulation by
determining the stability of ccn2 mRNA.
EXPERIMENTAL PROCEDURES
Cell Isolation and Culture—Chicken embryonic fibroblasts (CEF
cells) were isolated from a 10-day-old whole chicken embryo and main-
tained in Dulbecco’s modified Eagle minimum essential medium sup-
plemented with 10% fetal bovine serum (FBS) in humidified air con-
taining 5% CO2 at 37 °C. Chicken upper sternum chondrocytes (US
cells) and lower sternum chondrocytes (LS cells) were isolated from the
cephalic 1/3 portion and caudal 1/3 portion, respectively, of the sternal
cartilage of 18-day-old chicken embryos and maintained in high-glucose
Dulbecco’s modified Eagle minimum essential medium supplemented
with 10% FBS in humidified air containing 5% CO2 at 37 °C, as de-
scribed previously (41).
Growth Factors—Recombinant human BMP 2 and recombinant hu-
man PDGF-BB were purchased from R&D Systems (Minneapolis, MN)
and Sigma-Aldrich, respectively. Human recombinant CCN2 was pre-
pared as described previously (34).
Preparation for Hybridization—Clone A1/5 containing a full-length
chicken ccn2 was utilized as a probe for Northern blot analysis of the
ccn2 gene, as described in a previous study (41), and a 3 100-base
fragment of ccn2 3-UTR, which is described in another subsection of
this report, was utilized as a probe in the RNase protection assay. The
probes of chicken 2(I), 1(II), and 1(X) collagen genes, -actin gene,
and 18 S rRNA gene were obtained by reverse transcription-mediated
PCR, utilizing total cellular RNA of CEF cells (for 2(I) collagen gene)
or US cells (for the other genes) as a template. The nucleotide sequences
of the sense primer and antisense primer for 2(I) collagen (42) were
5-TTA CTC CTC GCG ACT GTA TGC-3 and 5-GCT CAC CAG GAA
CAC CTT GAA-3, respectively. For 1(II) collagen (43), the sense and
antisense primer sequences were 5-GCA GAG ACC ATC AAC GGC
GGT-3 and 5-CAG GCG CGA GGT CTT CTG CGA-3, respectively;
and those for 1(X) collagen (44), 5-AAG GGG CCA CAC TTT CTA-3
and 5-TTC TCC AGG CTT CCC TAT CCC-3, respectively. These 3
primer pairs were designed and previously utilized by Nakata et al.
(45). For chicken -actin (46), the nucleotide sequences of sense and
antisense primers were 5-TGG ATT TCG AGC AGG AGA TGG CC-3
and 5-TTA CTC CTA GAC TGT GGG GGA CTG-3, respectively; those
for chicken 18 S rRNA (47) were 5-GAC TCC GGT TCT ATT TTG TTG
G-3 and 5-ACT AGT TAG CAT GCC AGA GT-3, respectively.
The five amplicons were subcloned into pGEM T-Easy (Promega,
Madison, WI) by a TA-cloning method. Proper construction of all plas-
mids was confirmed by nucleotide sequencing, and one of the plasmids
by which the antisense strand mRNA can be transcribed from the
bacteriophage T7 polymerase promoter was selected and prepared for
each gene.
For hybridization, the plasmids of ccn2, 2(I), 1(II), 1(X) collagen,
and 18 S rRNA genes were utilized for the riboprobe preparation. The
plasmids were linearlized by SalI (for 18 S rRNA) or SpeI (for other
genes) and transcribed in vitro by bacteriophage T7 RNA polymerase in
the presence of 50 Ci of [-32P]CTP (3000 Ci/mmol, Amersham Bio-
sciences) for the preparation of radiolabeled antisense RNA. The tran-
scription reaction was performed at 37 °C for 1 h with reagents supplied
by the manufacturer (Promega), followed by RQ1 DNase (Amersham
Biosciences) digestion. The riboprobe of firefly luciferase was prepared
as described in a previous study (40). After transcription in vitro, all of
the riboprobes were subjected to spin-column (ProbeQuant G-50, Am-
ersham Biosciences) purification.
RNA Preparation and Northern Blot Analysis—Total cellular RNA
was isolated by use of Isogen (Nippon Gene, Tokyo, Japan), according to
the manufacturer’s protocol.
Northern blot analysis was carried out as described previously (41).
Total RNA was denatured by glyoxysal, separated on 1% agarose gels,
and then blotted onto nylon membranes (Hybond N, Amersham Bio-
sciences). After blotting, the membrane was fixed with 5% acetic acid
and stained with 0.02% methylene blue to visualize ribosomal RNAs,
hybridized, washed, and subsequently autoradiographed. The optical
density of each signal band of the autoradiography was quantified by
using commercial computer software (Quantity One, PDI Inc., New
York, NY).
Nuclear Run-on Analysis—Nuclear run-on assays were carried out
according to an established described protocol (48), with a slight mod-
ification. The nuclei of the cells grown in 10-cm tissue culture dishes
were isolated and suspended in 50 mM Tris-HCl (pH 8.0), 40% glycerol,
5 mM MgCl2, and 0.1 mM EDTA; aliquots of the suspension were then
incubated at 30 °C for 2 h with ATP, CTP, and GTP (each at 2.5 mM),
and 100 Ci of [-32P]UTP (3000 Ci/mmol, Amersham Biosciences) in a
reaction buffer consisting of 10 mM Tris-HCl (pH 8.0), 5 mM MgCl2, and
300 mM KCl. After digestion with RQ1 DNase and proteinase K (In-
vitrogen), the radiolabeled transcripts were extracted by using Isogen
LS (Nippon Gene) according to the manufacturer’s protocol, and further
purified by use of a spin column.
For preparation of membranes, the plasmids containing chicken
-actin and ccn2 were linearized by SpeI; whereas pGEM3Zf() (Pro-
mega) as a background control was linearized by EcoRI. The plasmids
were subjected to alkaline denaturation, and then 10 g of each was
dot-blotted onto a nylon membrane by use of a Bio-Dot apparatus
(Bio-Rad, Hercules, CA). Ten million cpm of radiolabeled nuclear tran-
scripts was hybridized to the blotted membranes at 42 °C for 72 h in
hybridization buffer consisting of 5 SSC (pH 7.0; 1 SSC  0.15 M
sodium chloride and 0.015 M sodium citrate), 5 Denhardt’s solution
(1 Denhardt’s solution  0.002% polyvinylpyrolidone, 0.02% Ficoll
400, and 0.02% bovine serum albumin (Sigma Aldrich)), 2% SDS, 50%
formamide, and 100 g/ml sonicated salmon testis DNA (Sigma Al-
drich). After hybridization, the membranes were washed twice at 65 °C,
for 20 min each time, in a wash buffer composed of 0.1 SSC (pH 7.0)
and 0.1% SDS and then autoradiographed. The optical density of each
dot was quantified by using Quantity One.
RNA Degradation Analysis and RNase Protection Assay—The cells in
10-cm tissue culture dishes were grown until subconfluent, and then 10
g/ml actinomycin D (Sigma Aldrich) was added to the cultures to
arrest de novo RNA synthesis. After properly timed intervals, total
cellular RNA was isolated and used for the RNase protection assay.
RNase protection assay was carried out with a commercial kit (RPA
III Kit: Ambion, Austin, TX), according to the manufacturer’s protocol.
Total RNA (3 g) was hybridized with 1  104 cpm of ccn2 or firefly
luciferase probe in the presence of 1  103 cpm of 18 S rRNA probe as
an internal control for 16 h at 42 °C. After hybridization, the RNA was
digested by an RNase A/T1 mixture, precipitated with ethanol, and
subjected to 6% PAGE in the presence of 7 M urea in 1 Tris borate-
EDTA (TBE; 90 mM Tris, 90 mM borate, and 2 mM EDTA) buffer. The
gels were subsequently dried and autoradiographed. The optical den-
sity of each signal band of the autoradiography was quantified by using
Quantity One.
Luciferase Constructs—The SV40 promoter-driven firefly luciferase
reporter plasmid (pGL3-control: Promega) was used to elucidate the
effects of chicken ccn2 3-UTR fragments, and a herpes simplex virus
thymidine kinase (HSV-TK) gene promoter-driven Renilla luciferase
expression plasmid (pRL-TK: Promega) was used as an internal control
for transfection experiments to monitor the transfection efficiency.
Plasmids pGL3L() and pGL3L() were described in a previous study
(38); the luciferase-chicken ccn2 3-UTR chimeric construct pGL3-
FULL() and another chimeric construct with a ccn2 3-UTR deletion
mutant, 3-400() were also described previously (41). Furthermore, in
the present study, four other deletion mutants of chicken ccn2 3-UTR
were constructed by using the same backbone. All of the mutants were
obtained by utilizing PCR technology from clone A1/5 (41), and the
primer sequences used to obtain the respective mutants were as follow:
5-TCT AGA TGC CTG TAT CCT TGC AAA G-3 for the sense primer of
3-200, 5-TCT AGA CTA TGG CTC TTT TTT TTT-3 for the sense
primer of 3-100 and 3-100/50, 5-TCT AGA CCA AAA GTT ACA TGT
TTG-3 for the sense primer of 3-50, 5-CGG AAT TCC GAT ATA AAA
AAT ATA AAT AC-3 for the antisense primer of 3-200, 3-100, and
3-50, and 5-GAA TTC AAA CAT GTA ACT TTT GGT C-3 for the
antisense primer of 3100/50. The sense and antisense primers con-
tained an XbaI and an EcoRI site, respectively. The amplicons were
double-digested with XbaI and EcoRI, purified, and subcloned between
the corresponding sites in pGL3L() or pGL3L(). Proper construction
of all plasmids was confirmed by nucleotide sequencing and restriction
enzymatic digestion analyses. Schematic representations of the molec-
ular constructs are shown in Fig. 3A.
DNA Sequencing and Computer Analysis—The cDNA subcloned into
each plasmid was sequenced by the dideoxy chain termination method
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(49) with a Big Dye Terminator Cycle Sequencing Ready Reaction Kit
version 2.0 (Applied Biosystems, Foster City, CA) and an ABI PRISM
310 Genetic Analyser (Applied Biosystems). DNA sequence alignment
and RNA secondary structure predictions were computed by using
commercial computer software, GENETYX-MAC version 10 (Software
Development, Tokyo, Japan).
DNA Transfection and Luciferase Assay—Twenty-four hours prior to
transfection, 2  105 cells were seeded into each of several 35-mm tissue
culture dishes. Cationic liposome-mediated DNA transfection was car-
ried out with 1 g of each pGL derivative in combination with 0.5 g of
pRL-TK, according to the manufacturer’s optimized methodology (Fu-
GENE6, Roche Applied Science). Forty-eight hours after the transfec-
tion, the cells were lysed in 500 l of a passive lysis buffer (Promega),
and the cell lysate was directly used for the luciferase assay.
The dual luciferase assay system (Promega) was applied for the
sequential measurement of firefly (reporter) and Renilla luciferase
(transfection efficiency standard) activities with specific substrates of
beetle luciferin and coelenterazine, respectively. Quantification of both
luciferase activities was done with a luminometer (TD20/20, Turner
Designs, Sunnyvale, CA), and calculation of relative ratios was carried
out manually.
Analysis of RNA Folding in Vitro—For preparation of template plas-
mids for in vitro transcription of cDNA corresponding to ccn2 3-UTR,
pGL3 derivatives containing the cDNAs were double-digested by XbaI
and EcoRI, purified, and subcloned between the corresponding sites in
pGEM3Zf(). In vitro transcription was carried out, as described in
another subsection. For synthesis of each sense RNA, the plasmid was
linealized by EcoRI and transcribed by Sp6 bacterial polymerase in the
presence of 50 Ci of [-32P]CTP (3000 Ci/mmol). For synthesis of
antisense RNA, the plasmid was linealized also by XbaI and transcribed
by T7 bacteriophage polymerase in the presence of 50 Ci of
[-32P]CTP. After spin-column purification, the radiolabeled RNAs
were analyzed by 6% PAGE in the presence of 7 M urea in 1
TBE buffer.
The RNA in vitro folding assay was carried out as described previ-
ously (40), with a slight modification. 50,000 cpm of radiolabeled RNA
was heated at 95 °C for 10 min, then gradually cooled to room temper-
ature in RNA folding buffer consisting of 10 mM HEPES (pH 7.9), 40 mM
KCl, 3 mM MgCl2, 1 mM dithiothreitol, 0.5 mg/ml yeast tRNA (Roche
Applied Science), and 0.5 mg/ml bovine serum albumin. After having
been cooled further to 4 °C, the RNAs were subjected to 6% native
PAGE analysis in 0.5 TBE. Subsequently, the analytical gels were
dried and autoradiographed.
RNA molecular size standards were produced via in vitro transcrip-
tion of a mixture of DNA templates (Century Marker, Ambion) in the
presence of [-32P]CTP. The radiolabeled RNA transcripts were sub-
jected to spin-column purification, and 1.5  104 cpm was used as an
RNA molecular standard in each experiment.
Preparation of Nuclear and Cytoplasmic Extraction—The nuclear
and cytoplasmic extracts were prepared by using a CelLytic NuCLEAR
Extraction Kit (Sigma Aldrich), according to the manufacturer’s proto-
col. The protein concentrations of both fractions were determined with
a BCA protein assay kit (Pierce), utilizing bovine serum albumin as a
standard (50).
RNA Electromobility Shift Assay (REMSA)—REMSA was carried out
according to the method described previously (51, 52), with a slight
modification. The nuclear or the cytoplasmic extract containing 0–10
g of protein was incubated at 25 °C for 30 min with 5  104 cpm of
radiolabeled RNA in 19 l of binding buffer (5 mM HEPES (pH 7.9), 7.5
mM KCl, 0.5 mM MgCl2, 0.1 mM EDTA, 0.5 mM dithiothreitol, 0.1 mg/ml
yeast tRNA, and 0.1 mg/ml bovine serum albumin). Then, the binding
mixture was incubated with 1 l of 1/100 diluted RNase mixture (0.5
unit/l RNase A and 20 units/l RNase T1, Ambion) for a further 10
min at 37 °C. The RNA-protein complex was subjected to 6% native
PAGE in 0.5 TBE buffer. The gels were subsequently dried
and autoradiographed.
For competition experiments, the extracts were preincubated with 20
ng of unlabeled competitor RNA for 30 min at 25 °C, followed by incu-
bation with the radiolabeled RNA for another 30 min at 25 °C.
UV Cross-linking Assay—RNA-protein binding reactions were car-
ried out as described in the subsection on REMSA. After RNase diges-
tion, the protein-RNA complexes were put on ice and UV-irritated for 10
min by a UV cross-linker (Amersham Biosciences). Then, the samples
were heated at 95 °C for 5 min in an SDS sample buffer (Sigma Aldrich)
in the presence of 5% 2-mercaptoethanol and separated by 12.5% or
4–20% gradient SDS-PAGE. The gels were subsequently dried
and autoradiographed.
Western Blot Analysis—Extracted proteins were heated at 95 °C for
5 min in SDS sample buffer in the presence of 5% 2-mercaptoethanol,
separated by 12.5% SDS-PAGE, and transferred to a polyvinylidene
difluoride membrane (Hybond P, Amersham Biosciences). The mem-
brane was then blocked with 5% skim milk in Tris-buffered saline for
16 h at 4 °C. After having been blocked, the membrane was next
incubated for 1 h at 37 °C with a 1/2,000 dilution of monoclonal
anti--tubulin antibody (Sigma Aldrich) or a 1/1,000 dilution of mono-
clonal anti-lamin B1 antibody (Zymed Laboratories Inc., South San
Francisco, CA) in Tris-buffered saline containing 0.05% Tween 20;
thereafter, it was incubated with a 1/20,000 dilution of a peroxidase-
conjugated goat anti-mouse IgG antibody (American Qualex, La
Mirada, CA) in Tris-buffered saline containing 0.05% Tween 20 for
1 h at 37 °C. Subsequently, the blot was visualized by using an ECL
Western blotting Analysis System (Amersham Biosciences) with
chemiluminescence detection.
Statistical Analysis—Unless otherwise specified, all experiments
were repeated at least twice, and similar results were obtained in the
repeated experiments. Statistical analysis was carried out by Student’s
t test if necessary. Data are expressed as the mean  S.D. p  0.05 was
considered significant.
RESULTS
Synthesis and Degradation Patterns of ccn2 mRNA Are De-
pendent Not Only on the Cell Type, but Also on the Differenti-
ation Stage of Chondrocytes—Previous studies of ours (22, 41)
revealed that ccn2 mRNA is strongly expressed in chondro-
cytes, particularly in hypertrophic chondrocytes. Therefore, we
were interested in whether de novo synthesis and/or degrada-
tion patterns of ccn2 mRNA were different among different
types of cells or not. Northern blot analysis (Fig. 1A) revealed
that ccn2 mRNA was expressed faintly in CEF cells, in which
only 2(I) collagen mRNA (a marker of fibroblasts and fibro-
blast-like cells) was expressed. In LS cells, in which 1(II)
collagen (a marker of mature chondrocytes) was moderately
expressed, ccn2 mRNA was more strongly expressed than in
CEF cells (1.5-fold). Moreover, in US cells, in which not only the
strongest expression of 1(II) collagen but also expression of
1(X) collagen (a marker of hypertrophic chondrocytes) was
observed, the expression level of ccn2 mRNA was remarkably
higher than that in CEF cells (2.5-fold) or in LS cells (1.6-fold).
These results indicate that de novo synthesis and/or degrada-
tion of ccn2 mRNA was different among these cells; hence, we
carried out a nuclear run-on assay and RNA degradation anal-
ysis to investigate the mechanism. The results of the nuclear
run-on assay (Fig. 1B) revealed that the transcriptional activ-
ity producing ccn2 mRNA was the strongest in US cells and
was moderate in LS cells, the findings of which are consistent
with the results of Northern blot analysis. The difference in the
relative transcriptional activity between CEF and LS cells was
likely to be the same as that in the relative amounts of their
steady-state mRNA (right panels of Fig. 1, A and B). However,
the transcriptional activity in US cells (right panel of Fig. 1B)
was at most 2-fold (versus CEF cells) and 1.4-fold (versus LS
cells) higher, indicating that the increased transcriptional ac-
tivity producing ccn2 mRNA did not fully support the increased
amounts of steady-state mRNA. The results of RNA degrada-
tion analysis (Fig. 1C) accounted for this discrepancy. The
stability of ccn2 mRNA in the LS cells was almost the same as
that in CEF cells (t1⁄2  1.0 h). However, in US cells, the ccn2
mRNA was more stable (t1⁄2  1.5 h) than in CEF or LS cells.
These results suggest that ccn2 mRNA should be regulated not
only at the transcriptional stage, but also at the post-transcrip-
tional stage, particularly by the regulation of the stability of
mRNA in chondrocytes. As such, post-transcriptional regula-
tion of ccn2 may play an important role in the regulation of
CCN2 protein production during maturation and differentia-
tion of chondrocytes.
Differential Response of ccn2 mRNA Stability to Growth Fac-
tors during Differentiation of Chondrocytes—It is reported that
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several growth factors stimulate the expression of ccn2 mRNA
in rabbit growth plate chondrocytes (22). Therefore, next we
analyzed whether the effects of the growth factors depended on
the regulation of mRNA stability and de novo synthesis of
mRNA or not. LS and US cells were stimulated with BMP2
(200 ng/ml), PDGF (10 ng/ml), or CCN2 (30 ng/ml) for 24 h in
the presence of 10% FBS, and then the cells were subjected to
Northern blot, nuclear run-on, and RNA degradation assays. In
the presence of 10% FBS, 24-h stimulation by the growth
factors had no significant effect on the transcriptional effi-
ciency of the ccn2 gene in the nuclear run-on assay (Fig. 2A).
However, RNA degradation analysis (Fig. 2B) demonstrated
that these growth factors changed the stability of ccn2 mRNA
differently, depending on the differentiation stage of the chon-
drocytes. In LS cells without growth factor stimulation, the
half-life of ccn2 mRNA was 60 min. However, the cells stim-
ulated by the growth factors uniformly showed significant in-
creases in mRNA stability. Most surprisingly, stimulation by
the growth factors significantly decreased ccn2 mRNA stability
in US cells, an effect contrary to that on the LS cells. Of note,
both the effect of increasing the stability in LS cells and that of
decreasing it in US cells were observed when the stimulator
was CCN2 itself. Taken together, these results suggest that the
post-transcriptional regulation may play important roles in
the precise control of the expression of ccn2 mRNA by altering
the stability of the mRNA.
Locating the Minimal cis-acting Repressive Element in 3-
UTR of Chicken ccn2 mRNA—It is widely known that 3-UTRs
of many genes possess signal sequences within them that de-
termine mRNA stability (53). Previous studies of ours revealed
that there exists a strong cis-acting repressive element in the
3-UTR of human (38–40) and murine (39) ccn2 mRNAs. Fur-
thermore, we recently obtained results (41) showing that the
400-base fragment at the 3-end of 3-UTR of chicken ccn2
FIG. 1. Steady-state level, transcrip-
tion efficiency, and degradation pat-
tern of ccn2 mRNA in chicken fibro-
blasts and chondrocytes. A, Northern
blot analysis of ccn2 and differentiation
marker mRNAs. Ten micrograms of total
RNA from each of CEF, LS, and US cells
was denatured by glyoxysal, separated on
1% agarose gel, and blotted onto a nylon
membrane. Prior to hybridization, the
membrane was stained with methylene
blue (28S) to show the equality of total
RNA. Hybridization with ccn2, 1 chain of
type X collagen (1(X)), 1 chain of type II
collagen (1(II)), and 2 chain of type I
collagen (2(I)) probes was sequentially
carried out, after stripping the former
probe. A representative result from three
individual experiments is shown in the left
panel. The relative mRNA level was nor-
malized by the 28 S rRNA level, and the
mean values of the three experiments are
displayed in the right panel with the value
for CEF cells set to unity and error bars
indicating S.D. *, p  0.05, significantly
different between the cells. B, nuclear
run-on assay of ccn2. Nuclear fraction from
CEF, LS, and US cells was isolated and
subjected to a nuclear run-on assay in the
presence of [-32P]UTP. Autoradiograms of
dot blot hybridization of ccn2, -actin as an
internal control, and pGEM3Zf() as a
negative control, are shown. A representa-
tive result from three individual experi-
ments is shown in the left panel, and the
relative value of ccn2 transcripts normal-
ized by the -actin level is displayed with
error bars indicating S.D. in the right
panel. *, p  0.05, significantly different
between the cells. C, RNA degradation
analysis. 10 g/ml actinomycin D (AcD)
was added to cultures of CEF, LS, and US
cells to terminate de novo RNA transcrip-
tion. After 0.5, 1, 2, and 3 h, total mRNAs
were isolated and subjected to the RNase
protection assay for ccn2 mRNA and 18 S
rRNA (18S). For the right panel, the rela-
tive value of ccn2 mRNA normalized by 18
S was first computed, and the obtained
value was standardized against the one for
time 0 of each cell (open circle, CEF; open
box, LS; and closed box, US). Results rep-
resentative of two individual experiments
are shown in the left panel, and the relative
values of ccn2 transcripts normalized by 18
S rRNA are displayed on the semi-loga-
rithm graph in the right panel. *, p  0.05,
significantly different from CEF cells.
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mRNA also contains a cis-acting repressive element. However,
the precise location of the minimal element remained to be
clarified. Therefore, we sought to identify this cis-element by
employing a transient expression and evaluation system using
firefly luciferase fusion constructs, as we had done in previous
studies (38–41).
As denoted in Fig. 3A, six chimeric firefly luciferase genes
were designed and constructed. These plasmids and parental
pGL3L plasmids were used for transfection, with Renilla lucif-
erase co-expression as an internal control, of CEF, LS, and US
cells, and a dual luciferase assay was then carried out (Fig. 3B).
In all three cell types, three deletion mutants, i.e. 3-200(),
3-100(), and 3-100/50() repressed luciferase gene expres-
sion in cis. FULL() did so as well. However, 3-50() demon-
strated much weaker cis-repressive effects than did the other
three deletion genes and FULL(). Of note, an antisense con-
struct, 3-100(), also showed a weak repressive effect. Fur-
thermore, the repressive effects of all of the fragments were
shown to be the strongest in CEF cells, moderate in LS cells,
and relatively weak in US cells. These results indicate that the
minimal element of chicken ccn2 3-UTR for the cis-repressive
effect on gene expression was located within the region of
3-100/50 in an orientation- and cell type-dependent manner.
Accelerated Degradation of a Reporter RNA by Repressive
Elements in the 3-UTR of Chicken ccn2 mRNA in cis—As
described in a previous subsection, chicken ccn2 3-UTR re-
pressed the expression of the reporter gene in cis. So next we
investigated the effect of the fragments of 3-UTR on the sta-
bility of cis-linked mRNA, utilizing RNA degradation analysis
for the luciferase gene (Fig. 4). In all transfectants, luciferase
mRNA was highly expressed, because SV40 is a very strong
promoter. In the control, the half-life (t1⁄2) of the luciferase
mRNA was 45 min. In contrast, the mRNA containing the
3-100() or 3-100/50() 3-UTR fragment was rapidly de-
graded (t1⁄2  15 min). The 3-50() chimeric mRNA was also
degraded more rapidly than the control; however, its effect was
quite modest. These results are consistent with those of the
luciferase assay and suggest that the 3-UTR of chicken ccn2
FIG. 2. Effects of growth factors on the synthesis and degradation of ccn2 mRNA in LS and US cells. A, nuclear run-on assay. LS and
US cells were stimulated with BMP2 (200 ng/ml), PDGF (10 ng/ml), or CCN2 (30 ng/ml) for 24 h in the presence of 10% FBS. Then, nuclear fractions
were isolated and subjected to the nuclear run-on assay in the presence of [-32P]UTP. Autoradiograms of dot blot hybridization of ccn2, -actin
as an internal control, and pGEM3Zf() as a negative control are shown. A representative from three individual experiments is shown in the left
panel; the relative values of ccn2 transcripts normalized by -actin, and standardized against the one for the control () without growth factor,
along with error bars indicating S.D., are displayed in the right panel. B, RNA degradation analysis. LS and US cells were stimulated with BMP2
(200 ng/ml), PDGF (10 ng/ml), or CCN2 (30 ng/ml) in the presence of 10% FBS. After 24 h, 10 g/ml actinomycin D (AcD) was added. Then, after
0, 0.5, 1, and 2 h, total RNAs were isolated and subjected to the RNase protection assay for ccn2 mRNA and 18 S rRNA (18S). The results
representative of two individual experiments are shown in the left panel, and the computed half-lives (t1⁄2) of ccn2 mRNA normalized by those of
18 S are displayed in the right panel.
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mRNA contains one or more RNA elements that destabilize the
mRNA in cis, probably within the area between 50 and 100
bases from the polyadenyl tail.
Secondary Structure Formation of RNA Fragments of the
3-UTR of Chicken ccn2 mRNA—It is also recognized that the
cis-acting sequences in various mRNAs are able to form compact
secondary structures (40). In line with this general finding, the
fragments of 3-UTR of chicken ccn2 mRNA, which conferred
cis-repressive effects on reporter gene expression, were very rich
in adenosine-uridine (AU-rich, Fig. 5), and computer analysis
predicted that the RNAs of 3-100 and 3-100/50 could form stable
secondary structures (data not shown). Thus, an RNA in vitro
folding assay was carried out. In vitro transcription of those
template cDNAs in the presence of [-32P]CTP provided high
quality corresponding RNAs that gave single bands with the
expected electrophoretic mobility in 6% urea-denatured PAGE
gels (Fig. 6A). Thereafter, the RNAs were forwarded to extensive
in vitro folding assay (Fig. 6B). After heat denaturation and
re-naturation by gradual cooling in the folding buffer, structured
forms of 3-100() and 3-100() RNA fragments were observed,
FIG. 3. Identification of minimum functional cis-acting element in the chicken ccn2 3-UTR for gene expression. A, schematic
representation of the structures of the plasmids utilized in this study. The 3-half of the ccn2 mRNA, including the 3-UTR is illustrated at the top,
and the full-length and deletion mutant fusion constructs are displayed. Full-length and deletion mutants of ccn2 3-UTR were connected in the
sense direction to the 3-end of the firefly luciferase gene of parental pGL3L(). Only in 3-100() (bottom of the panel) was the 3-UTR fragment
placed in the antisense direction (see “Experimental Procedures”). B, relative firefly luciferase activities from the chimeric luciferase genes. The
chimeric firefly luciferase constructs in panel A and pRL-TK containing Renilla luciferase gene (internal control) were used to co-transfect CEF,
LS, and US cells. After 48 h, the cells were lysed, and the dual-luciferase assay was carried out. Activity is presented as a relative value of the
measured luminescence of firefly luciferase versus Renilla luciferase, which was standardized against the parental control (100%) for each cell type.
Mean values of the results of three experiments are displayed with error bars of S.D. *, p  0.05, significantly different from each control.
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which confer higher electromobility than the unfolded form, in
native 6% PAGE gels. A similar mobility-shift was also distinc-
tively observed with 3-100/50() RNA, although the change in
electrophoretic mobility itself was modest. In contrast, no folded
form was observed in the case of the 3-50() RNA fragment
under the same conditions. These results demonstrate that the
folding efficiency of RNAs in vitro is consistent with the repres-
sive effects on reporter gene expression in vivo, suggesting that
the secondary structure formation of the corresponding fragment
of 3-UTR of ccn2 mRNA may be an important determinant for
the repressive post-transcriptional regulation of gene expression.
Binding Profile of Nuclear and Cytoplasmic Protein(s) to
3-UTR Fragments of ccn2 mRNA in Vitro—The results de-
scribed in previous subsections suggest that these self-folded
fragments might be able to bind specific nuclear and/or cyto-
plasmic protein(s). To explore this point further, we conducted
REMSA and UV cross-linking assays. As shown in Fig. 7A, an
RNA mobility shift was observed by incubating the 3-100
fragment with the nuclear and cytoplasmic extracts of CEF
cells. Interestingly, the shifted RNA band, which resulted from
binding with the nuclear protein, was stronger than that with
the cytoplasmic protein. The 3-50 fragment, which was not
able to form a secondary structure in the in vitro folding assay,
bound to neither the nuclear protein nor the cytoplasmic pro-
tein. However, the 3-100/50 fragment showed almost the same
result as obtained for the 3-100 fragment. The results of the
UV cross-linking assay (Fig. 7B) clearly indicate that 3-100
and 3-100/50 fragments were able to bind not only to the
protein in the cytoplasmic extract, but also to the protein in the
nuclear extract, with the latter giving much stronger signals.
These findings are in agreement with the results of REMSA.
Furthermore, these results also suggest that the bound protein
in each extract may be identical and indicate that the molecu-
lar mass of the protein was 40 kDa.
Subsequent competition analysis confirmed the specificity of
the observed interaction. Namely, co-incubation with an unla-
beled competitor of the 3-100 fragment completely abolished
the RNA mobility-shift (Fig. 7C) and cross-linked signals (Fig.
7D) that resulted from the binding of 3-100 and 3-100/50
fragments to nuclear and cytoplasmic proteins. In the same
way, an unlabeled competitor of the 3-100/50 fragment also
completely abolished the specific interaction. In contrast, the
unlabeled 3-50 fragment had no effect on the gel-shift or cross-
linked signals, indicating that 3-50 fragment was unable to
compete with either 3-100 or 3-100/50 fragments in binding to
nuclear and cytoplasmic proteins. These results indicate that
the minimal element in the 3-UTR of chicken ccn2 mRNA for
binding to the putative 40 kDa-trans factor is present within
the 3-100/50 portion.
Profile of Binding of cis-Element in 3-UTR of ccn2 mRNA to
the Putative trans-Factor during Differentiation of Chondro-
cytes—The results in previous subsections showed that, de-
pending on the differentiation stage of chondrocytes, the puta-
tive chicken ccn2 mRNA undergoes post-transcriptional
regulation through its mRNA stability and suggested the in-
volvement of a repressive regulatory system enabled by the
cis-element and putative trans-factor. These findings prompted
us to examine whether the binding of the cis-element to the
putative trans-factor protein is dependent on the differentia-
tion stage of chondrocytes or not. Therefore, utilizing the nu-
clear and cytoplasmic extracts of CEF, LS, and US cells, we
conducted extensive REMSA and UV cross-linking analysis. As
shown in Fig. 8A, a gel-shift was observed for radiolabeled
3-100 RNA (left panel) or 3-100/50 RNA (right panel) incu-
bated with nuclear or cytoplasmic protein. Overall, it is clear
that the signals indicating RNA-protein interaction were much
stronger with proteins from LS cells than with those from US
cells. Interestingly, incubating the probe with the cytoplasmic
protein of LS cells gave the most prominent shifted bands.
More interesting, the results of the gel-shift analysis revealed
quite opposite patterns of the subcellular distribution of the
binding protein between US and LS cells. The UV cross-linking
assay (Fig. 8B) showed the same results as those of REMSA. By
incubating the probe with the cytoplasmic protein of LS cells, a
single band corresponding to the binding protein of putative
40-kDa trans-factor was observed most prominently. Incuba-
tion with the nuclear protein of LS cells also yielded a band of
the same density. In contrast, in US cells, no signal was de-
tected with the cytoplasmic protein, whereas the binding signal
was still distinct with the nuclear protein. The results of West-
ern blotting analysis (Fig. 8C) for lamin B1 (a nuclear protein)
and -tublin (a cytoplasmic protein) clarified the quality and
quantity of each protein fraction. As such, no remarkable dif-
ferences were observed among the cells tested. Therefore, we
suggest that the amount and/or the binding affinity of the
putative trans-factor protein interacting with the cis-element
of the 3-UTR of ccn2 mRNA might be regulated differentially
among cell types, particularly among differentiation stages of
chondrocytes. Furthermore, we propose that regulation of bind-
ing between the cis-element and the putative trans-factor
might play an important role in the differentiation and matu-
ration of chondrocytes by regulating the stability of the
ccn2 mRNA.
Profile of binding of cis-Element of ccn2 mRNA to Putative
40-kDa trans-Factor Is Regulated by Growth Factors during
Maturation of Chondrocytes—Finally, we investigated whether
or not the growth factors that were shown to affect the stability
of ccn2 mRNA, as described in a previous subsection, would
also affect the binding between the cis-element and putative
trans-factor. So, we carried out a UV cross-linking assay (Fig.
9A), utilizing the nuclear and cytoplasmic fraction of LS and
US cells stimulated with BMP2 (200 ng/ml), PDGF (10 ng/ml),
or CCN2 (30 ng/ml) for 24 h in the presence of 10% FBS. In LS
cells (left panel), these growth factors decreased the binding of
the probe to the putative 40-kDa nuclear trans-factor. Further-
more, all of the growth factors abolished the binding of the
probe to the cytoplasmic protein almost completely. On the
contrary, in US cells (right panel), all of the growth factors
increased the binding of the probe to the 40-kDa nuclear puta-
FIG. 4. Effects of cis-acting element in the chicken ccn2 3-UTR
on RNA stability. CEF cells were transfected with the chimeric firefly
luciferase constructs (Full(), 3-100(), 3-50(), and 3100/50())
illustrated in Fig. 3A. After 48 h, 10 g/ml actinomycin D (AcD) was
added. Then, after 0, 0.5, and 1 h, total RNAs were isolated and
subjected to RNase protection assay for firefly luciferase mRNA (luc).
The results representative of two individual experiments are shown.
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tive trans-factor protein. However, the growth factors had no
effect on binding to the cytoplasmic protein, and thus no band
was observed. Western blotting analysis (Fig. 9B) of fraction
markers confirmed the quality and quantity of each protein
fraction. Taken together, the observed differential effect of the
growth factors on the binding profile between LS and US cells
suggest that the regulatory system through binding of the
cis-element of the 3-UTR of ccn2 mRNA to the 40-kDa putative
trans-factor protein might regulate the expression of ccn2
mRNA during differentiation of chondrocytes. In particular,
this regulatory system might play an important role in chon-
drocyte differentiation through feedback regulation of the
mRNA expression by autocrine CCN2 protein.
DISCUSSION
In the present study, we demonstrated that chicken ccn2
mRNA was expressed moderately in LS cells, in which the
phenotypes of proliferating chondrocytes were expressed, and
prominently in US cells, in which the phenotypes of prehyper-
trophic-hypertrophic chondrocytes were expressed (Fig. 1A).
The results of the nuclear run-on assay (Fig. 1B) revealed that
the transcriptional activity of the ccn2 gene was almost corre-
lated with the mRNA level. Indeed, the stability of mRNA (Fig.
1C) of LS cells was the same as that of CEF cells (t1⁄2  1.0 h).
However, importantly, in US cells, the mRNA was the most
stable (t1⁄2  1.5 h), suggesting post-transcriptional regulation
of mRNA stability in the ccn2 gene regulatory system. In cul-
tured rabbit growth plate chondrocytes, ccn2 mRNA expression
was also observed at a peak level at the hypertrophic stage (22).
Furthermore, in situ hybridization revealed that its expression
was predominant in hypertrophic chondrocytes of the mouse
growth plate (22); and recombinant CCN2 protein stimulated
the proliferation, proteoglycan synthesis, expression of type II
and type X collagen genes, and alkaline phosphatase activity of
rabbit growth plate chondrocytes (22, 34, 54). Therefore, these
studies together suggest that regulation of the transcription
activity producing ccn2 mRNA and that of its stability may
control the proper growth and differentiation of chondrocytes
during endochondral ossification.
It has been reported that ccn2 mRNA was induced in various
cells by various growth factors, such as BMP 2 (22), PDGF (28),
and CCN2 itself (22). These growth factors have also been re-
ported to play an important role in growth and differentiation of
chondrocytes (8–11). Nonetheless, in the present study, the re-
sults of the nuclear run-on assay (Fig. 2A) demonstrated that
24-h stimulation with BMP2, PDGF, or CCN2 had little effect on
the de novo synthesis of ccn2 mRNA in chicken chondrocytes.
This is partly because the cells were exposed to the growth
factors for only a short time (24 h) and 10% FBS was present in
the medium. In the presence of FBS, which contains a variety of
factors, some stimulatory and some inhibitory toward growth
and differentiation, the response of de novo synthesis of ccn2
mRNA to the growth factors might have been masked. For dras-
tic enhancement of de novo synthesis of ccn2 mRNA, continuous
stimulation for a long period of time might be required as well.
FIG. 5. Nucleotide sequences and orientation of radiolabeled transcripts. Four 32P-labeled ccn2 RNAs were prepared for in vitro folding
analysis, REMSA, and UV-cross linking assay. The 3-100, 3-50, and 3100/50 cDNA fragments of ccn2 3-UTR shown in Fig. 3A were
double-digested with EcoRI and XbaI and subcloned between the corresponding sites of pGEM3Zf(). These plasmids were linearized by digestion
with EcoRI or XbaI, and in vitro transcription by bacteriophage T7 or Sp6 RNA polymerase was carried out in the presence of [-32P]CTP. The three
transcripts designated 3-100(), 3-50(), and 3-100/50() were sense transcripts of the 3-UTR with the sequence denoted at the top of the panel.
In contrast, the transcript named 3-100() possessed an antisense strand sequence of the corresponding region (see “Experimental Procedure”).
The AUUUA and AUUUA-like sequences, which are regarded as destabilizing mRNA cis-elements, are indicated by underlined boldface type.
FIG. 6. Preparation and in vitro
folding of radiolabeled RNA frag-
ments of ccn2 3-UTR. A, analysis of the
synthesized RNAs in urea-denatured 6%
PAGE. Four 32P-labeled RNAs were pre-
pared. RNA size markers (Century Mark-
er; Ambion) are shown at the left side of
the panel. B, in vitro folding assay of the
radiolabeled RNAs. The RNAs were
heated at 95 °C and gradually cooled to
room temperature to allow them to form a
secondary structure. Then, the RNAs
were analyzed by electrophoresis through
6% native PAGE gels. Arrowheads indi-
cate secondary-structured RNA.
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FIG. 7. Profile of binding of the nuclear or cytoplasmic protein(s) of CEF cells to the ccn2 3-UTR RNA. A, REMSA of the RNA
fragments of ccn2 3-UTR. Three radiolabeled and folded RNA probes (3-100, 3-50, and 3-100/50) corresponding to the ones shown in Fig. 5 were
incubated with or without () 10 g of nuclear extract (N) or cytoplasmic extract (C) of CEF cells. After RNase digestion, the mixtures were
analyzed by electrophoresis through 6% native PAGE gels. At the bottom of the gel, RNase-digested free probes are observed. B, UV cross-linking
assay of the RNA fragments of ccn2 3-UTR. The radiolabeled and folded RNA probes were incubated with the extract, and digestion with RNase
was performed as for REMSA. Then, the mixtures were irradiated by UV on ice and analyzed by SDS-PAGE in a 4–20% gradient gel. Positions
of molecular standards (Rainbow Marker, Amersham Biosciences) are shown at the left side of the panel. At the bottom of the gel, RNase-digested
free probes are observed. C, competition analysis of the REMSA. Twenty nanograms of unlabeled RNAs was preincubated with the extracts. Then,
radiolabeled probes were added, and REMSA was carried out as described above. D, competition analysis of the UV cross-linking assay. Twenty
nanograms of unlabeled RNAs was preincubated with the extracts. Then, radiolabeled probes were added, and UV cross-linking assay was carried
out as described above except that the SDS-PAGE was carried out in a 12.5% gel. Positions of molecular standards are shown at the left side of
the panel. RNase-digested free probes are seen at the bottom of the gels.
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On the other hand, RNA degradation analysis (Fig. 2C) revealed
that the growth factors did affect the stability of ccn2 mRNA. Of
note, the response of the stability of ccn2 mRNA to the growth
factors was different between LS and US cells. Namely, by stim-
ulation with the growth factors, the stability of mRNA was in-
creased in LS cells and decreased in US cells, showing the exact
opposite effects between two different stages (proliferating stage
versus prehypertrophic-hypertrophic stage) of chondrocytes.
Therefore, we were led to hypothesize that the gene expression of
ccn2 might be regulated by a bi-directional feedback loop, chang-
ing from positive to negative during chondrocyte differentiation.
In this regard, although gene expression of ccn2 in vivo has been
shown to be the highest in hypertrophic chondrocytes (3, 22),
detailed observation revealed that the ccn2 expression during the
differentiation of growth cartilage cells was the highest in early
hypertrophic (non-calcified hypertrophic) chondrocytes and then
decreased in chondrocytes in the calcified zone (22). In addition,
an in vitro culture system of rabbit growth cartilage cells showed
that the up-regulated expression of ccn2 in hypertrophic chon-
drocytes decreased as the cells differentiated during the calcify-
ing stage (22). Therefore, it is feasible that growth factors that
promote the terminal differentiation (calcification followed by
apoptosis) of chondrocytes, such as BMP-2 (55) and CCN2 (3, 54),
would down-regulate the expression level of ccn2 in the US cells,
which mainly consist of prehypertrophic and hypertrophic chon-
drocytes. So far, there has been no report on the effect of PDGF
on the terminal differentiation of growth plate chondrocytes, but
it would be interesting to investigate the effect of this factor on
hypertrophic chondrocytes, because they have been reported to
be stainable with anti-PDGF antibodies (56). The physiological
FIG. 8. Different profiles of binding
of the putative trans-factor to ccn2
3-UTR among cell types. A, REMSA of
the ccn2 3-UTR probes with nuclear or
cytoplasmic extracts of CEF, LS, and US
cells. The radiolabeled and folded probes
(3-100 and 3-100/50) were incubated
with or without () 10 g of nuclear ex-
tract (N) or cytoplasmic extract (C) of
CEF, LS, or US cells. After RNase diges-
tion, the mixtures were analyzed by elec-
trophoresis through 6% native PAGE
gels. At the bottom of the gels, RNase-
digested free probes are also visible. B,
UV cross-linking assay. The radiolabeled
and folded RNA probes were incubated
with the extract and then digested with
RNase as performed in REMSA. Then,
the mixtures were irradiated by UV on ice
and analyzed by SDS-PAGE in a 4–20%
gradient gel. Positions of molecular
weight standards are shown at the left
side of the panel. At the bottom of the gels,
RNase-digested free probes are also visi-
ble. C, Western blotting analysis. 10-g
proteins of each extract was subjected to
12.5% SDS-PAGE and blotted onto a poly-
vinylidene difluoride membrane. The blot
was then incubated with anti-lamin B1 or
anti--tublin antibody.
Regulation of Chicken ccn2 among Chondrocytes 3175
significance of the switch from positive to negative regulation is
unknown. However, because forced overexpression of ccn2 has
been shown to induce apoptosis of cells (57) and because the
highest basal expression level was observed in the US cells (Fig.
1A), further stimulation by such factors may activate the nega-
tive feed-back loop of mRNA degradation to avoid overproduction
of CCN2, which might cause early apoptosis before calcification.
It is widely known that mRNAs of a number of genes contain
cis-elements in their 3-UTRs to regulate their protein expres-
sion, through export from nuclei to ribosomes (58) and stability
(53). Of note, both mammalian and avian ccn2 mRNAs possess
1.1-kbp-long 3-UTRs, which contain strong cis-acting elements
that repress on gene expression (38–41). Therefore, we sought
to define the minimum cis-element in the 3-UTR of chicken
ccn2 mRNA by employing a transient expression and evalua-
tion system with firefly luciferase fusion constructs. Thereby,
we demonstrated that the element was located 100 bp up-
stream from the 3-end of the mRNA and that the effect was
orientation-dependent (Fig. 3). Importantly, the repressive ef-
fect of each potent fragment appeared weaker in CEF, moder-
ate in LS, and more prominent in US cells. These findings
suggest that the discrepancy in mRNA stability (Fig. 1C) be-
tween these cells might be the outcome of the negative regula-
tion by the mRNA portion. Furthermore, RNA degradation
analysis (Fig. 4) directly revealed that these fragments accel-
erated degradation of the reporter gene in cis and that the
minimal fragment for repression of gene expression was re-
quired for the rapid RNA degradation. These results suggest
that one or more cis-elements in the 3-UTR of chicken ccn2
mRNA play an important role in the post-transcriptional reg-
ulation of ccn2 gene through RNA degradation.
Indeed, nucleotide sequence analysis of this portion (Fig. 5)
revealed that this region was highly AU-rich and contained
AUUUA and AUUUA-like sequences, which have been re-
garded as mRNA-destabilizing cis-elements interacting with
trans-factors in mammalian species (59–62). Therefore, we
regard the fragment “3-100/50” as a major negative regulatory
cis-element in the 3-UTR of chicken ccn2 mRNA and consider
it to be related to the destabilization of the mRNA.
Previous studies in other laboratories (60, 63, 64) showed
that such AU-rich RNA sequences are capable of forming a
secondary structure and that a unique stem-loop or bulge of
3-UTR is characteristic of the trans-factor binding site for
post-transcriptional regulation. Furthermore, AU-rich ele-
ments in 3-UTR of several proto-oncogenes, such as c-myc (59),
hormones, such as parathyroid hormone (62), and cytokines,
such as granulocyte-macrophage colony stimulation factor (65),
have been recognized as signal targets for rapid degradation,
which contributes, in part, to the rapid turnover of their
mRNAs. As to chicken ccn2 mRNA, computer analysis pre-
dicted that the corresponding RNA portions of 3-100() and
3-100/50() were capable of forming stable secondary struc-
tures. RNA in vitro folding analysis (Fig. 6B) actually revealed
that these RNA fragments formed secondary structures; how-
ever, no folded form was observed in the case of the 3-50()
RNA fragment. These results, taken together with those of the
reporter gene assay, thus suggest that the stable self-folding of
the portion “3-100/50” may contain the regulatory center that
interacts with a putative trans-factor, playing the role of a
negative regulator of gene expression, probably acting as an
RNA destabilizer in cis.
Next, we investigated the putative trans-factor(s) that bound
to the cis-element of the 3-UTR of chicken ccn2 mRNA.
REMSA (Fig. 7A) and UV cross-linking assay (Fig. 7B) revealed
that 3-100/50 fragment as well as 3-100 fragment bound
40-kDa nuclear and cytoplasmic proteins of CEF cells. The
competitor analysis of each experiment (Fig. 7, C and D) con-
firmed that the binding was probe-specific, suggesting the pro-
tein to be a putative trans-factor with the capacity to bind to
the cis-element in the 3-UTR of ccn2 mRNA. Hence, the 40-
kDa protein that bound to the 3-100 fragment is likely to be
identical to the one that bound to the 3-100/50 fragment.
Further REMSA (Fig. 8A) and UV cross-linking assays (Fig.
8B) revealed the distinct patterns of binding of the putative
trans-factor to the radiolabeled probes between LS and US
cells. Namely, the binding profile of the nuclear and cytoplas-
mic proteins of LS cells was opposite to that of US cells. In
particular, unlike in the case of CEF and LS cells, only very
faint binding was detected by incubation with the cytoplasmic
protein of US cells. Considering the fact that ccn2 mRNA was
more stable in US cells than in CEF and LS cells (Fig. 1C), the
40-kDa putative trans-factor may destabilize ccn2 mRNA by
interacting with cis-element in the 3-UTR. Indeed, the prom-
inent binding between the cis-element and the factor in LS cells
might induce rapid degradation of ccn2 mRNA, and the de-
creased binding in US cells might contribute to the strong
expression of ccn2 mRNA in them. It is also of note that the
binding signal for the cytoplasmic putative trans-factor disap-
FIG. 9. Growth factor modulation of the binding of the putative trans-factor in LS and US cells to ccn2 3-UTR. A, UV cross-linking
assay of ccn2 3-UTR probes with nuclear and cytoplasmic extracts of LS and US cells stimulated by growth factors. LS and US cells were
stimulated with BMP2 (200 ng/ml), PDGF (10 ng/ml), or CCN2 (30 ng/ml) for 24 h in the presence of 10% FBS; and nuclear (N) and cytoplasmic
(C) extracts were then prepared. The radiolabeled and folded probes were incubated with or without () 10 g of the extracts. After RNase
digestion, the mixtures were irradiated by UV and analyzed by 12.5% SDS-PAGE. Positions of molecular weight standards are shown at the left
side of the panel. At the bottom of the gel, RNase-digested free probes are observed. B, Western blot analysis. 10-g proteins of each extract was
subjected to 12.5% SDS-PAGE and blotted onto a polyvinylidene difluoride membrane. The blot was then incubated with anti-lamin B1 or
anti--tublin antibody.
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peared upon stimulation by the growth factors that extended
the half-life of ccn2 mRNA in US cells (Fig. 9). These findings
indicate that this regulated mRNA degradation is carried out
mostly in the cytoplasm.
A number of laboratories, including ours, have reported im-
portant physiological or pathological roles of CCN2, such as
promotion of cell growth and differentiation in development
(22, 34), angiogenesis (32), and wound healing (28). In addition,
ccn2-overexpressing transgenic mice presented a dwarfism
phenotype and decreased bone density (66), whereas ccn2-null
mice showed skeletal dysmorphisms as a result of impaired
chondrocyte proliferation (67), showing the critical importance
of the strict regulation of CCN2 gene expression during endo-
chondral ossification. Therefore, proper expression of ccn2 dur-
ing the course of differentiation of chondrocytes in development
should be regulated at a variety of stages, such as transcrip-
tional, post-transcriptional, and translational. Indeed, previ-
ous studies of ours revealed that detectable expression of ccn2
mRNA was three-dimensionally highly restricted (22) and that
the 1.1-kbp-long 3-UTR contained cis-element that repressed
gene expression (38–41). However, the precise role of the cis-
element during differentiation of chondroytes had remained
unclear. In the present study, we first showed that the expres-
sion of chicken ccn2 mRNA was regulated not only at the
transcriptional level, but also at the post-transcriptional level,
and that the post-transcriptional regulation was based on the
modulation of mRNA stability by the interaction between a
cis-element in the 3-UTR and a putative 40-kDa-trans-factor
in the nuclei and cytoplasm. Moreover, we also demonstrated
that this interaction was differentially regulated through the
differentiation stages of chondrocytes. It is of particular inter-
est to us to pursue the minimal cis-element in the 3-UTR and
to identify the putative trans-factor, to define better the post-
transcriptional regulation system of ccn2. Further investiga-
tion is currently in progress.
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